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Abstract-Design of a machine learning algorithm as a ro-
bust class predictor for various DNA microarray datasets is a
challenging task, as the number of samples are very small as
compared to the thousands of genes (feature set). For such
datasets, a class prediction model could be very successful in
classifying one type of dataset but may fail to perform in a
similar fashion for other datasets. This paper presents a
Stacked Regression Ensemble (SRE) model for cancer class
prediction. Results indicate that SRE has provided perform-
ance stability for various microarray datasets. The perform-
ance of SRE has been cross validated using the k-fold cross
validation method (leave one out) technique for BRCA1,
BRCA2 and Sporadic classes for ovarian and breast cancer
microarray datasets. The paper also presents comparative re-
sults of SRE with most commonly used SVM and GRNN. Em-
pirical results confirmed that SRE has demonstrated better
performance stability as compared to SVM and GRNN for the
classification of assorted cancer data.
Index Ternm-Support Vector Machines, Neural Networks,
Stacked Generalization, Decision Based Fusion and Classifier
Ensemble.
I. INTRODUCTION
Machine leaming algorithms have been successfully applied
to many bioinformatics applications [1] including diagnosis
of breast [15], ovarian [1, 15], leukemia [16], lymphoma
[17], brain cancer [18] and lung cancer [19]. Despite this
success, there is still an awareness of the need for robust
classification algorithms which exhibit performance stabil-
ity for multiple types of data. Some classifiers have better
classification results for one type of data, but fail to perform
in a similar way for another data set. The reason of such
variability in performance is due to lack of separability of
data and much more number of features (thousands of
genes) as compared to the number of samples in microarray
data. This problem can be addressed if different classifier
types are integrated to form an ensemble to identify a par-
ticular class [26, 27 and 28] so that best performance of the
classifiers can be combined.
There are several techniques to combine multiple classi-
fiers for example, sum, product, minimum, maximum, me-
dian and majority voting [21, 22, 23, 24 and 25]. The ad-
vantage of these techniques is that they are simple and do
not require training [31], though this is countervailed by the
fact that they are not adaptive to the input data. Stacked
generalization however, has emerged as a way to ensemble
classifiers adaptively and requires further training for fusing
the decision of different classifiers [8, 30]. This classifier
fusion however requires careful selection of base classifiers
[7] to achieve acceptable misclassification rates.
This paper presents Stacked Regression Ensemble (SRE)
which used SVM with different kemels including Linear,
Polynomial and Radial Basis Function (RBF) and General-
ized Regression Neural Network (GRNN) as base classifi-
ers. The motivation to use SVM- and GRNN was their prom-
ising results in a variety of biological classification tasks,
including gene expression microarrays. SVM has demon-
strated better classification accuracy while classifying vari-
ety of microarray data than other commonly used classifiers
[3, 14 and 32]. However, our research has demonstrated that
if Generalized Regression Neural Networks (GRNN) is
modified to add a distance layer it can perform better than
SVM in the classification of genetic data [15]. Our experi-
mental results will confirm that our proposed fusion models
will perform consistently better than single classifiers in-
cluding SVM and GRNN.
The well known ovarian cancer microarray data by Amir
et al [36] and breast cancer data by Hedenfalk et al [37] is
used for comparative purposes. The reason to address this
classification problem present in the above data sets is due
to the fact that cancer is one of the most appalling diseases
for researchers due to its diagnostic difficulty and devastat-
ing effects on human kind. Some types of cancer are more
dangerous than others for example, breast cancer is the sec-
ond leading cause of cancer deaths in women today (after
lung cancer) and is the most common cancer among
women, excluding non-melanoma skin cancer and ovarian
cancer [34]. Similarly ovarian cancer is the fourth most
common cause of cancer related deaths in American women
of all ages as well as being the most prevalent cause of
death from gynaecologic malignancies in the United States
[35]. Mutations in BRCA1, BRCA2 and Sporadic (without
BRCA1 and BRCA2 mutation) are responsible for heredi-
tary breast and ovarian cancer that can lead to carcinogene-
sis through different molecular pathways [36], so disease
pathway mapping is helpful for the treatment of this disease
in efficient way. If there is a family history of a particular
gene mutation then this implies a possible mutation in the
descendents, so we can combine the knowledge ofgene mu-
tation and family history for a more accurate and timely
identification of ovarian and breast cancer.
This paper is organized as follows: section 2 outlines dif-
ferent class prediction algorithm used as base classifiers and
for comparative purposes. Section 3 presents our proposed
SRE model and methodology. Results and discussion on our
experimental results are provided in section 4. Finally, sec-
tion 5 concludes the paper.
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II. CLASS PREDICTION MODELS
Subject to the condition
This section briefly reviews GRNN and SVM classification
techniques that will be used in evaluating and building our
proposed SRE model. A detailed review of these methods is
provided by [2, 4 and 14].
A. Generalied Regression Neural Network
Generalized regression neural networks are paradigms of
the RBF used in functional approximation [20, 21]. To ap-
ply GRNN to classification, an input vector x (ovarian or
breast cancer microarray data) is formed and weight vectors
W are calculated using (2). The output y(x) is the weighted
average of the target values 'k of training cases xi close to a
given input case x, as given by:-
n
32t,W
y(X)= i='
n
i=l
(1)
y, (W.Zi + b) >1 (5)
Using the Kuhn-Tucker condition [26] and LaGrange Mul-
tiplier methods in (7) is equivalent to solving the dual prob-
lem
Max[ a, 2Ea,ajayK(xxi)] (6)
where 0 < ai < C, 1 = number of inputs, i = . and
I
Laqy, = 0. In (9) K(xi ,x) is the kemel function and in our
i=1
experiments, a linear, polynomial (of degree 2 to 20) and
RBF functions were used C is the only adjustable parameter
in the above calculations and a grid search method is used
to select the most appropriate value of the C.
where W = exp[ Ax -x 112]
The only weights that need to be leamed are the smoothing
parameters, h of the RBF units in (2), which are set using a
simple grid search method. The distance between the com-
puted value y(x) and each value in the set of target values T
is given by:-
T = {1, 2} (2)
The values 1 and 2 correspond to the training class and all
other classes respectively. The class corresponding to the
target value with the minimum distance is chosen. As,
GRNN exhibits a strong bias towards the target value near-
est to the mean value ,u of T [14] so we used target values I
and 2 because both have the same absolute distance from lu.
B. Support Vector Machine
Support vector machines are systems based on regulariza-
tion techniques which perform well in many classification
problems [17, 22]. SVM converts Euclidean input vector
space lR' to higher dimensional space [18, 19] and attempts
to insert a separating hyperplane [23, 24 and 25]. The gene
expression data Z is transformed into higher dimensional
space. The separating hyperplane in higher dimension space
satisfies:-
III. STACKED REGRESSION ENSEMBLE
Classifier ensemble is used to increase the posteriori predic-
tion performance. In the past several methods have been
proposed to ensemble classifiers like Minimum, Maximum,
Median, Majority Vote and Stacked Generalization. Com-
prehensive details for classifier fusion are provided by [7, 8
and 9]. However, due to adaptive behavior of stacked gen-
eralization it has proven to be a better technique than the
techniques given in [7].
Fig. 1 demonstrates the working of SRE. For a given
data Lo = {(y.,xn)V n-1,2,....N} where Yn is the class label, x,
is a data sample and N is the total number of samples avail-
able in the data set. The input data Lo is first divided equally
in k folds k, ...k,. The individual classifiers, (SVM with lin-
ear, polynomial and RBF kemel and GRNN) referred to as
base classifiers or level-0 generalizer [10] are then cross
validated by removing each fold randomly from k folds in
such a way that selection probability P, for a particular fold
to be used as validation data D is :-
pI, _ - )'
NxL (7)
W.Zi + b =0 (3)
To maximize the margin between genetic mutation classes
(5) and (6) are used.
MaxI
11W112 (4)
and the probability P, to become part of training data
F = LO- b is :-
-
(k
-1)x1q
NxL (8)
where N = total data items per class, k= number of folds, L
= number of classes and I = number of samples in each
fold. For each ith iteration class prediction posteriori prob-
832
ability Pp, of class co, for the given data x can be calculated
as
Ppi=P(coi x) (9)
After entire cross validation process k prediction labels
based on prediction probabilities Pp are assembled as
LI = {(y.,Pp5)V n=1,2,....k} to get level-I data. Then, GRNN,
level-I generalizer [11] is trained based on LI and the output
is considered to be final output ofSRE [12, 131 (See Fig. 1).
ers. The other reason is that the ensemble can only be accu-
rate than its base classifiers when base classifiers disagree
with each other [33] and in this case the classifiers in en-
sembles performance is better than the best accuracies of
individual base classifiers.
TABLE 1: CLASSIFICATION ACCURACIES OF OVARIAN CANCER (B 1 =
BRCA1, B2 = BRCA2 AND S = SPORADIC)
Classification Models B1 B2 S
Ensemble SRE 94 84 91
Individual GRNN 94 75 81
Classifiers SVM-Linear 94 66 78
SVM-RBF 88 78 75
SVM-Poly 94 69 81
For example, the classification accuracy of SRE for
BRCA2 mutation is better than the best accuracies of the
rest of models due to the reason that these models showed
different class results while classifying the same sample.
Similarly, the better classification results for Sporadic ge-
netic mutation of SRE is not due to class separability rather
it is hard to classify as compared to the other mutations (see
Fig. 2). The reason for better results by SRE for Sporadic
mutation classification is due to the presence of SVM with
polynomial kernel and GRNN as base classifiers (whose
individual accuracy is maximum for the classification of
Sporadic mutations) and their different behavior while clas-
sifying the same sample.
Fig. 1: Stacked Regression Ensemble 1.025r
1.021
IV. RESULTS AND DISCUSSION
To compare the different classification models, ovarian can-
cer data by Amir et al [36] and breast cancer data by Heden-
falk et al [37] is used for the experimental purpose. The
ovarian cancer data set contains 18, 16 and 27 samples of
BRCA1 mutations, BRCA2 and sporadic mutations (neither
BRCAI nor BRCA2) respectively. Each data sample con-
tains logarithmic microarray data of 6445 genes. There are
21 samples for the breast cancer data that contains 7, 7 and
8 samples of BRCA1 mutations, BRCA2 and sporadic mu-
tations (neither BRCA1 nor BRCA2) respectively and each
data sample contains microarray data of 3226 genes. The
microarray data is asymmetric, so log2 of the input data is
used to make data symmetric. This logarithmic data is then
used as the input to the classifier to identify the mutation of
genetic data.
Results in Table 1 show that our proposed SRE model
has demonstrated higher classification accuracy as com-
pared to single models, including SVM (with Linear, Poly-
nomial and RBF kernel) and GRNN for the class prediction
of BRCA1 and Sporadic mutations in ovarian cancer. The
reason of these better results is the adaptive behavior of
GRNN as level-I generalizer. For example, SVM with RBF
kernel performed better than rest of single classifiers and
GRNN adapted to give it more weight while classifying
BRCA2 mutations as compared to the rest of base classifi-
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Table 2: Classification accuracies of breast cancer (B 1 =
BRCA1, B2 = BRCA2 and S = Sporadic)
Classification Models Bi B2 S
Ensemble SRE 100 93 93
Individual GRNN 86 93 93
Classifidul SVM-Linear 64 86 86
SVM-RBF 64 64 64
SVM-Poly 71 93 86
Table 2 shows that for breast cancer data SRE again outper-
formed rest of the models for the classification of BRCAI
and Sporadic mutations. However, performance accuracy of
SRE for BRCA2 and Sporadic mutation (see table 2) is not
833
better than the best accuracies of base classifiers due to the
reason that all the classifiers misclassified the same sample.
So, assembling classifiers using proposed Staked regression
technique can perform better than the best accuracies of in-
dividual base classifiers if the classifiers differ in decisions
otherwise it is never less than the best accuracies of individ-
ual classifiers.
V. CONCLUSIONS
This paper has presented staked regression ensemble which
has shown consistent performance when used for ovarian
and breast cancer microarray data sets as compared to single
machine leaming algorithm, including SVM and GRNN.
Our proposed models have shown improved classification
accuracies of 94%, 84% and 91% for ovarian cancer data
for BRCAI1, BRCA2 and Sporadic mutations respectively
for ovarian cancer data. The respective accuracies of SRE
for breast cancer data are 100%, 93% and 93% for the
aforementioned mutations. The SRE model demonstrated
better classification accuracies than the best accuracies of
individual base classifiers when they differ in the class pre-
diction results. However, the proposed model has accuracy
equal to the best accuracy of base classifier when the base
classifiers don't differ in class prediction results. So, com-
bining classifiers in such a way gives either better accuracy
than the best accuracy of base classifiers or at least it pro-
vides the same classification performance as can be demon-
strated by the best base classifiers. Therefore, the better
classification results for multiple datasets demonstrate the
ability of our innovative SRE model to classify various
types of data more accurately.
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